Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
By Kevin Dawson, VP, Information Services, Los Angeles Biomedical Research Institute
IT executives are expected to be business leaders responsible for the information services function from end-to-end and not just the custodians of the IT infrastructure....
By Ilkka Salminen, Director, Life Sciences, Deloitte Consulting
The exponential growth of technologies such as the IoT, data storage, bandwidth and processing power will enable the healthcare industry to shift irrevocably towards a more digitised operating model.
By Sid Nair, VP & GM, Healthcare and Life Sciences, Dell Services
Until recently, the validity of the results from statistical modeling rested upon meeting the model’s underlying assumptions and whether the sample accurately.
By Brad Swarbrick, owner, Quality by Design Consultancy
What this translated to, compared to the traditional approach to process validation, is that the three batch validation system is no longer acceptable and a Continuous Verification approach must be adopted.
By Christy Wilson, Senior Director, Pharma & Biotech Segment, Elsevier R&D Solutions
Today, pharmaceutical companies are increasingly adopting "proactive PV" to help ensure the safety of a new entity as early as possible in the discovery/development process.
By Ashwin Athri, SVP, Precision for Value
The discipline of master data management (MDM) has gained momentum in biopharma recently.
By Michael Swanick, Global Pharmaceutical and Life Sciences Industry Leader, PwC
Technological advances, empowered consumers, disruptive new entrants, and rising demand by an aging population are ushering in a new era in healthcare—what we at PwC call the “New Health Economy.”
By Michele C. D'Alessandro, VP & CIO, Manufacturing IT, Merck
The manufacturing world is undergoing its fourth industrial revolution, known as Industry 4.0, spurred by the proliferation of digital capabilities (Internet of Things), and the integration.
By William Leonard, ScD, Chief Information Officer, MPI Research
Cloud computing is certainly a game changer for all industries, especially for Biotech. Like many other biotech companies, our usage of cloud computing is, at present, limited to non-study, administrative systems.
By Rhonda Medows, M.D., EVP of Population Health, Providence St. Joseph Health And Deepak Sadagopan, VP of Population Health informatics and government programs, Providence St. Joseph Health
With the increasing emphasis on value-based care, population health will continue as a driving force for American health systems.
By William Paiva, Executive Director, Oklahoma State University's Center for Health Systems
Health care is undergoing significant transformation, and digital health data is at the center of this change. According to the Centers for Disease Control, nearly 80 percent of the nation’s health care institutions.
By Ramin Daron, VP, Data Architecture and Technology, R&D Data Science Institute at Takeda Pharmaceuticals International Co
Continuing progressive enhancement of the data factory, we apply these learnings in pursuit of better health.
By Sharon Kaiser, CIO and Director of IT, New England Biolabs, Inc.
New England Biolabs (NEB) was founded in the mid-1970s and is one of the oldest biotech companies in the world. It was founded by scientists and is committed to developing innovative products for the life sciences industry.
By Paul Blake, Associate Director, GEP Worldwide
To re-imagine what is possible, without the limits that the status-quo imposes, and to work out how best to use our intellect and creativity
By Jeffrey Keisling, CIO and SVP, Pfizer
Genomics data and the broad implementation of electronic medical records, there are more opportunities than ever to leverage technology to better serve the needs of patients.
